Jonathan Lim isn't ready to say much about his new startup, but he does have $42M for it
Jonathan Lim knows how to build biotechs for a sale. He auctioned off Ignyta — where he was CEO — to Roche last February for a tidy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
